BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27230481)

  • 21. Recovery of the neurosensory retina after macular translocation surgery is independent of preoperative macular sensitivity in neovascular age-related macular degeneration.
    Mettu PS; Sarin N; Stinnett SS; Toth CA
    Retina; 2011 Sep; 31(8):1637-49. PubMed ID: 21775925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The longitudinal impact of macular telangiectasia (MacTel) type 2 on vision-related quality of life.
    Lamoureux EL; Maxwell RM; Marella M; Dirani M; Fenwick E; Guymer RH
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2520-4. PubMed ID: 21217104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "En face" optical coherence tomography imaging in type 2 idiopathic macular telangiectasia.
    Wolff B; Basdekidou C; Vasseur V; Sahel JA; Gaudric A; Mauget-Faÿsse M
    Retina; 2014 Oct; 34(10):2072-8. PubMed ID: 25255245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
    Kovach JL; Rosenfeld PJ
    Retina; 2009 Jan; 29(1):27-32. PubMed ID: 18936721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between autofluorescence abnormalities and visual acuity in idiopathic macular telangiectasia type 2: MacTel project report number 5.
    Balaskas K; Leung I; Sallo FB; Clemons TE; Bird AC; Peto T
    Retina; 2014 Aug; 34(8):1630-6. PubMed ID: 24743635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasia.
    Schmitz-Valckenberg S; Fan K; Nugent A; Rubin GS; Peto T; Tufail A; Egan C; Bird AC; Fitzke FW
    Arch Ophthalmol; 2008 Mar; 126(3):330-5. PubMed ID: 18332311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel clinical sign in macular telangiectasia type 2.
    Jindal A; Choudhury H; Pathengay A; Flynn HW
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):134-6. PubMed ID: 25559527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal bevacizumab for type 2 idiopathic macular telangiectasia.
    Veloso CE; Vianna RN; Pelayes DE; Nehemy MB
    Ophthalmic Res; 2013; 49(4):205-8. PubMed ID: 23364325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RESTORATION OF RETINALLY INDUCED ANISEIKONIA IN PATIENTS WITH EPIRETINAL MEMBRANE AFTER EARLY VITRECTOMY.
    Han J; Han SH; Kim JH; Koh HJ
    Retina; 2016 Feb; 36(2):311-20. PubMed ID: 26352554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of idiopathic retinal vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation.
    Krivosic V; Massin P; Desjardins L; Le Hoang P; Tadayoni R; Gaudric A
    Am J Ophthalmol; 2014 Jul; 158(1):154-161.e1. PubMed ID: 24631475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of Coats' disease with visual recovery from no light perception vision after vitrectomy.
    Yamashita T; Kawamura H; Kojo N; Ohji M
    Jpn J Ophthalmol; 2011 Jan; 55(1):78-80. PubMed ID: 21331702
    [No Abstract]   [Full Text] [Related]  

  • 32. Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization.
    Do DV; Bressler SB; Cassard SD; Gower EW; Tabandeh H; Jefferys JL; Bressler NM
    Retina; 2014 Oct; 34(10):2063-71. PubMed ID: 24978428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phakic cystoid macular edema secondary to idiopathic macular telangiectasia type 1 responsive to topical anti-inflammatory agents.
    Dunn EN; Gregori NZ; Goldhardt R
    Semin Ophthalmol; 2013 Mar; 28(2):84-7. PubMed ID: 23448562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodal Imaging in Adult-Onset Coats' Disease.
    Sakurada Y; Freund KB; Yannuzzi LA
    Ophthalmology; 2018 Apr; 125(4):485. PubMed ID: 29566865
    [No Abstract]   [Full Text] [Related]  

  • 35. Dexamethasone implant for the treatment of edema related to idiopathic macular telangiectasia.
    Sandali O; Akesbi J; Rodallec T; Laroche L; Nordmann JP
    Can J Ophthalmol; 2013 Aug; 48(4):e78-80. PubMed ID: 23931489
    [No Abstract]   [Full Text] [Related]  

  • 36. CONE DENSITY LOSS ON ADAPTIVE OPTICS IN EARLY MACULAR TELANGIECTASIA TYPE 2.
    Jacob J; Krivosic V; Paques M; Tadayoni R; Gaudric A
    Retina; 2016 Mar; 36(3):545-51. PubMed ID: 26418443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.
    Helb HM; Charbel Issa P; VAN DER Veen RL; Berendschot TT; Scholl HP; Holz FG
    Retina; 2008 Jun; 28(6):808-16. PubMed ID: 18536596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASSOCIATION BETWEEN CHANGES IN MACULAR VASCULATURE IN OPTICAL COHERENCE TOMOGRAPHY- AND FLUORESCEIN- ANGIOGRAPHY AND DISTRIBUTION OF MACULAR PIGMENT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
    Zeimer M; Gutfleisch M; Heimes B; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2015 Nov; 35(11):2307-16. PubMed ID: 26465618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time course of changes in aniseikonia and foveal microstructure after vitrectomy for epiretinal membrane.
    Okamoto F; Sugiura Y; Okamoto Y; Hiraoka T; Oshika T
    Ophthalmology; 2014 Nov; 121(11):2255-60. PubMed ID: 25012933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultra wide field angiography in the diagnosis of aneurysmal retinal telangiectasia: a case report.
    Bohórquez MC; Navarro R; Corcóstegui B
    Semin Ophthalmol; 2009; 24(1):15-8. PubMed ID: 19241286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.